Home › Trial NCT01607905
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
- Trial IDNCT01607905
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorKaryopharm Therapeutics Inc
- Enrollment192
- Start date2012-06-18
- ConditionsSolid Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.